Archimedes, Inc. Expands Use Of Big Data In Healthcare Modeling And Analytics

Archimedes, Inc., a healthcare modeling and analytics company, announced recently that it is substantially expanding its modeling and analytics solutions. New product offerings and disease models will enable users to more quickly and easily access and analyze information related to their complex questions. Archimedes customers will be able to further enhance their modeling and analytic projects by integrating their own electronic health records (EHR), claims, clinical trial, and pharmacokinetic/pharmacodynamic (PK/PD) simulation outcomes data with data from Archimedes simulations and proprietary algorithms. This integrated data will be accessed and analyzed through novel interfaces that offer near-instant results.

For more than ten years, the company has been working to proactively identify new opportunities where big data can play a role in the healthcare continuum – from research and development to the point of patient care. The advancements, which will become available throughout 2013, represent Archimedes’ continued commitment to its vision of revolutionizing medicine worldwide through mathematics.

“At Archimedes, we are dedicated to harnessing the power of big, real-world data by developing healthcare modeling and analytics tools,” said David Eddy, M.D., Ph.D. founder of Archimedes and pioneer in the area of evidenced-based medicine. “We are continually developing tools that can help researchers, life-science organizations, government agencies, payers, and providers get the most from the available data. Archimedes is excited to announce that, starting today, we will be providing free access through our website to new, easy-to-use tools for addressing some of healthcare’s most complex questions.”

Since inception, Archimedes has been striving to improve efficiencies in the healthcare system by developing quantitative methods for analyzing healthcare decisions at the individual and population levels. The tools, including the new ARCHeS Population Explorer, take modeling and analytics a step further by delivering big data to the fingertips of users, making it easier and faster to gather, enhance, and analyze multiple datasets. In the current era of accountability in medical decision making, it is critical that actionable data analytics tools are made available to the people who need them most.

The Archimedes Model is the most advanced mathematical modeling tool available to answer complex questions regarding health and healthcare. It is a clinically realistic, trial-validated, mathematical model of human physiology, diseases, interventions, and healthcare systems. By using advanced methods of mathematics, computing, and data systems, the Model enables researchers and decision makers to make better informed decisions. Archimedes continually validates the Model by comparing the results of simulated trials to the results of multinational clinical trials and cohort studies. The Model is the foundation behind the various solutions offered by Archimedes – including ARCHeS, the population-focused research platform, and IndiGO, the clinical-decision support tool for use by physicians and patients at the point-of-care.

About ARCHeS
ARCHeS can be used to answer a wide variety of questions and analyze problems related to cardio-metabolic risk, COPD, nephropathy, and CHF. Archimedes recently expanded ARCHeS by adding new tools for big data analysis and visualization that enable data sources such as electronic health records (EHRs), clinical trial data, Archimedes Model simulation output, and claims data to be combined into a single analysis platform. Free access to basic ARCHeS functionality is available via Archimedes’ website

About IndiGO
The IndiGO solution delivers the power of big data to the fingertips of consumers and providers. IndiGO analyzes person-specific health information from a patient’s EHR, and then applies advanced algorithms which incorporate clinical evidence related to diseases, behaviors, and interventions. The results generated by IndiGO provide a graphical representation of an individual’s risk of having a heart attack or stroke and developing diabetes, as well as the predicted impact of interventions, such as lifestyle changes and medications, that are most effective at reducing these risks. IndiGO and individualized guidelines can be used at the point of patient care, involving the patient in the decision making process and improving collaboration between patient and provider. New components will be added to this tool in the coming months. Consumers can access IndiGO via a new app developed by Marshfield Clinic under an award from the Centers for Disease Control and Prevention’s Million Hearts program.

About Archimedes, Inc.
Archimedes Inc. is a healthcare modeling and analytics organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions, and healthcare systems. Archimedes continually validates the Model by comparing the results of simulated trials to the results of multinational clinical trials and cohort studies. Through products such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions. For the last 15 years, Archimedes has assisted health plans, health systems, medical groups, patients, pharmaceutical companies, researchers, and other organizations in the United States and Europe answer questions related to health and economic outcomes research, policy creation, clinical trial design, and performance improvement.  Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California. For more information, visit www.archimedesmodel.com.